newsfilter
← Latest News
PR Newswire·

Ampio Pharmaceuticals Reports Fourth-Quarter and Full-Year 2021 Financial Results and Operational Highlights

Cash and Cash Equivalents of $34 Million Expected to Fund Current Operations into 2H 2023 Company to host Conference Call Tuesday, March 29, 2022, at 4:30pm EDT ENGLEWOOD, Colo., March 29, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE:AMPE)